Quantcast
Channel: China Entertainment News
Viewing all 18266 articles
Browse latest View live

William Chan unveils his wax replica

$
0
0

Singer and actor William Chan poses for a photo with his wax replica which was inducted into the new music zone of Madame Tussauds in Beijing on July 5, 2018. 

Chan is honored by Madame Tussauds to be the first ambassador of the music zone. 

Source: china.org

Street shots of Guli Nazha

$
0
0

Actress Guli Nazha


Source: Xinhua

Xi Mengyao covers fashion magazine

‘Jurassic World’ Sequel Tops $1 Billion Mark, Boosted by China

$
0
0

(Bloomberg) “Jurassic World: Fallen Kingdom,” the latest dinosaur sequel from Universal Pictures, topped $1 billion in global box-office sales, helped by a warm reception in China and other overseas markets.

The film has grossed $304.8 million in North America and $700.7 million in other countries, the division of Comcast Corp. said on Friday. “Fallen Kingdom,” which was released on June 22, becomes the 35th movie to reach the $1 billion mark, based on data from Box Office Mojo.

China -- an important market for Hollywood -- was a bright spot for the film. It grossed $245.2 million in the country, making it the top overseas market, Universal said. That contrasts with the lackluster showing of another sci-fi picture this year: “Solo: A Star Wars Story” didn’t resonate with Chinese audiences, contributing to its weak global performance.

“Fallen Kingdom” picks up where the last “Jurassic World” movie ended, with dinosaurs rampaging through the fictional Isla Nublar. Chris Pratt reprises his role as the fearless Owen Grady, this time trying to save the dinosaurs from a volcano and trophy hunters. The series dates back to 1993, when the original “Jurassic Park” from Steven Spielberg was released.

The latest film still has one major market debut: It opens in Japan on July 13.

Source: Bloomberg By Nick Turner

Tearjerker film portrays true story of China's medical progress

$
0
0

A new film has soared to critically-applauded triumph and great box office success, while capturing a phenomenal story reflecting China's medical reform and progress since the early 21st century. 
New talents meet old talents
"Dying to Survive" is a drama inspired by real life that uses dark humor to portray the struggle for survival of leukemia patients who resorted to asking a drug dealer to smuggle unapproved, cheap drugs from India into China. The drug dealer later finds his redemption and becomes a hero. The film is the work of emerging director Wen Muye, with the support of two big comedy filmmakers, Xu Zheng and Ning Hao.
This also marks the fifth collaboration between Xu and Ning, yet this lucrative summer season is the first time in 12 years that the two have teamed up. In those years, the two have been trying to discover and help new directing talents and good screenplays. This time they served as executive producers and bet on Wen, who rose to prominence in 2013 for directing the award-winning short film "Battle" at the FIRST International Film Festival in Xining, Qinghai province. "Dying to Survive" is his first feature-length film.
The 117-minute "Dying to Survive" is more on the serious side than the making-people-laugh side, but still carries a positive message. "I have always paid attention to realistic subject matter, and want to give people hope from despair," Wen told China.org.cn. "I will continue to make this kind of heartwarming film."
An instant hit
The popularity of the film has continued to rise since its premiere at the 21st Shanghai International Film Festival, where it received seven rounds of standing ovations. In recent days, limited advanced screenings have begun around China and the film has taken in more than 150 million yuan (US$22.53 million) at box offices, a staggering test result. Some film critics are calling it China's "Dallas Buyers Club" meets "Schindler's List."
The good news led the producers and distributors to release it one day ahead of schedule, on Thursday, and on its opening day – a normal working day – it grossed another 160 million. This brought the total gross to 323 million yuan (about US$48.52 million) even before its original release date of Friday arrived. 
Meanwhile, on the film review site Douban.com, the film's rating stands at 9/10 based on 153,700 reviews from users, a rare high score for a domestic-made film. Industry insiders have already predicted it will hit the 3-billion-yuan (US$450 million) mark in the near future if the full potential of the film is unleashed. 
"I believed 'Dying to Survive' will surpass 'Operation Red Sea,'" actor Zhang Yi said excitedly after attending an advanced screening in Beijing on Tuesday. Dante Lam's "Operation Red Sea," which Zhang starred in, grossed 3.64 billion yuan (US$546.94 million) earlier this year and is the second highest-grossing Chinese film in history. 
From real life to the screen 
"With courage, facing reality and challenges, the film is a work of conscience, responsibility and love," director Gu Changwei said in praise of the film. 
The power of "Dying to Survive" is drawn from a true story. Lu Yong, a textile entrepreneur who was diagnosed with leukemia in 2002, proceeded to smuggle into the country the unapproved Indian-made generic version of Gleevec – originally developed and manufactured by Swiss drug company Novartis – for himself and many others to get treatment at an affordable price. The man was detained by police in Yuanjiang, Hunan province in 2014 for allegedly selling counterfeit drugs. He was seen as a charitable hero and later more than 1,000 leukemia patients wrote to China's authorities begging for mercy. The prosecution dropped the case against him and released him in 2015. 
His legend touched Han Jia'nyu, a new screenwriter in the industry, after she saw a TV program about him in 2015. "I cried many times when I searched for information about this man," she said. Han also admitted that when she created the script, she was influenced by the Steven Soderbergh film "Erin Brockovich." This was her first script to be adapted into a film, thanks to director Ning Hao who was also touched by the story. 
Her script was then reworked by the director Wen and another script writer, who changed the leading role from a leukemia patient to a drug dealer, in order to make the film more dramatic. But this move angered the original inspiration for the story, Lu Yong. 
"I never wanted to make money from my fellow patients," Lu said, "I thought this film would hurt my image. I don't want to say I'm a hero, but I'm just a patient who also helped others somehow. The role in the film is very different from myself."
But after corresponding with the film's creators, Lu Yong started to understand the creative changes that were made. He was satisfied with the final cut of the film after viewing it at an advanced screening held in Tsinghua University on Monday.
"You can rest assured that the audience will understand and see it clearly," Xu Zheng, who stars as the main character in the film, told Lu at the ceremony after the screening, "The drug dealer part belongs to me, the hero part belongs to you." Lu was relieved after receiving a standing ovation and round of cheering. That night, the film's producers and creators also pledged a donation of 2 million yuan (over US$300,000) to China's leukemia patients. 
A reflection of progress
Lu also said the film portrays what happens when people can't afford the high price of imported drugs. He agreed with the message at the end of the film that the situation is improving thanks to recent efforts by the government.
To address the issue of overpricing and to ease the financial burden of cancer patients and their families, the State Council of China pledged in May of this year to adopt a combination of different measures. They include removing tariffs from imported cancer drugs, slashing VATs and altering import procedures, as well as prompting procurement by the centralized government and the incorporation of much-needed cancer drugs into the medical insurance reimbursement catalog.
"It is very different now; very few patients approach me for Indian drugs," Lu added. "This film reflects that era, and also reflects the progress of China."
A touching moment occurred at the end of the promotional event at Tsinghua University, during which the audience members en masse turned on the phone flashlights to shine starry lights of hope. 
Lu's friend Yi Ran and fellow patient Li Qun, who is also a retired policeman and poet, stepped up on stage to read a poem by Li that served as a tribute to life: "Life and death are very close / To bloom or to fall takes only an instant / A long road lies ahead, but heaven and sunshine are not actually far away / With the coolness of autumn rain and the warmth of the morning sun / I come back alive from heaven, and know spring is everywhere in the world."
Source: china.org by zhang rui

Zhou Xun poses for photo shoot

Liu Yifei releases new photo

Wang Ou covers fashion magazine


China Box Office: ‘Dying to Survive’ Hits $200 Million After Opening Weekend

$
0
0

(variety) Chinese comedy drama, “Dying to Survive” opened with a massive $151 million to be the second largest film across the world this weekend. Its cumulative score by Sunday stands fractionally short of $200 million.

Based on real events, about a cancer survivor who took it on himself to import cheap drugs from India, the film is an unlikely winner in terms of subject matter. The film, directed by first time feature maker Wen Muye, changes the lead role to a non-patient, creating parallels with “Dallas Buyers Club.”

The picture got commercial traction by starring comedy titan Xu Zheng, veteran of “Lost in Thailand” and “Breakup Buddies,” and was powered by strong social media interest. It was the first Chinese-language film in 16 years to score 9 out of 10 on the Douban rating site. Adding to the film’s pedigree, Xu also co-produced with serial hitmaker Ning Hao (“Crazy Stone,” “No Man’s Land”). It premiered last month at the Shanghai International Film Festival.

After four days of successful previews, worth $48 million, the film was given a maximum push by exhibitors. Releasing with 167,000 screenings, it raced off to a $36.1 million Friday, according to data from Ent Group. On Saturday, it expanded to 187,000 sessions for $57.8 million, and followed that on Sunday with $57.2 million from 193,000 screenings.

The cumulative according to Ent was $199.7 million. The total included $5.7 million earned from 532 IMAX screens.

Chinese comedy, “New Happy Dad and Son 3: Adventure in Russia” took second place with a decent $10.5 million in three days.

Chinese action adventure, “Animal World” took third place with $8.57 million. After 10-days its cumulative is $64.3 million.

“Jurassic World: Fallen Kingdom” took fourth place. It added $5.53 million for a 23-day score of $243 million.

“Incredibles 2” fared less well. Having never reached top spot, it sank to fifth place, scoring $3.30 million. Its cumulative after 17 days on release is $47.9 million.

No other film achieved more than $1 million over the weekend. “Escape Plan 2: Hades” was the best of the rest, scoring $330,000 for a 10-day total of $13.4 million.

Source: Variety By Patrick Frater

New Chinese drama ‘Legend of Fu Yao’ sees sharp contrast in domestic and overseas reviews

$
0
0

(Global Times) New TV drama Legend of Fu Yao, starring well-known Chinese actress Yang Mi and actor Ruan Jingtian, has seen mixed reactions among audiences both in China and abroad since it debuted on June 18.

Airing on Zhejiang Television and v.qq.com, a major video streaming platform in China, the period fantasy show tells the story of Fu Yao, a young woman from the bottom rung of society who experiences all kinds of hardships as she adventures through dangerous and surprising foreign lands.

The TV series is based on a Chinese novel that has large fan base in the country. The first episode received more than 300 million views within a few hours of its debut. However, while viewership has been high, reviews have been harsh. Currently the show holds only a 4.8/10 on Douban, a major Chinese media review platform.

Criticism of the show has mainly focused on what viewers consider cliché plots and a "Mary Sue" protagonist. Other viewers have taken issue with storylines that they feel are very "similar" to those found in the novel Harry Potter and the Goblet of Fire.

Despite the wide criticism at home, the show has had quite the opposite reception overseas. The drama is currently one of the top popular Chinese shows on viki.com, an online platform where Asian TV shows with multi-language subtitles are available. The show has a high grade of 9.7/10, the same as that of the hugely popular 2015 historical drama Nirvana in Fire. Praise and applause for the show have filled the comment section on the platform. 

"She [the main character Yang Mi] is perfect here with just the right mix of playfulness, intelligence, charm, skill and beauty. Wonderful performance that easily reminds me of her star turn in Ten Miles of Peach Blossoms," netizen bailey1 commented in a post that has received 196 likes.

"Everything in this drama works so well and I wish it could go on forever," commented another netizen gabbi_watches_dramas.

The show has also made it to the pages of overseas media outlets. The Daily Pakistan has reported that the show has garnered "appreciation in Pakistan," while calling the show "a wonderful presentation of Chinese characteristics. Each scene in it looks like a Chinese ink painting."

However, despite divided reviews, the show's popularity remains high both at home and abroad.

China's unique Xianxia (Lit: immortal hero) dramas, which feature a mix of Chinese martial arts and mythology, have been drawing in a growing number of overseas fans in recent years with their imaginative plots and fantastical worlds. 

Shows such as Nirvana in Fire, The Journey of Flowers, Ten Miles of Peach Blossoms and Noble Aspirations have gained large numbers of fans overseas, along with the original novels on which these dramas are based. Stars in those shows, including Wang Kai, Yang Mi and Zhao Liying, have also earned themselves loyal fan bases outside of China.

The high reviews overseas is possibly the result of this combination of "Xianxia fever" and strong support from overseas fans of these Chinese stars.

Source: Global Times by He Keyao 

Actor Li Guangjie poses for fashion magazine

Pop actress Yang Mi covers fashion magazine

$
0
0

Actress Yang Mi


Source: China Daily

Shu Qi covers fashion magazine

China Vows to Cut Cost of Cancer Drugs as Blockbuster Film Highlights Issue

$
0
0

(THR) China has vowed to accelerate its efforts to cut the costs of lifesaving cancer drugs, a move many are viewing as a response to a local blockbuster that highlights the social ills caused by overpriced medication in the country.

Regulators will "speed up price cuts for cancer treatments," the state-backed People's Daily reported over the weekend. The announcement was made just as Dying to Survive, a social drama about the plight of cancer patients, stormed Chinese cinemas, earning a whopping $200 million in four days and another $32 million on Monday.

As of 5 p.m. Beijing time on Tuesday, the film had added another $15 million in box-office revenue.

Local box-office analysts expect the film to earn over $600 million, which would make it one of China's biggest blockbusters ever.

Directed by Wen Muye and starring Xu Zheng, Dying to Survive tells the real-life story of a Chinese businessman who illegally smuggled generic cancer medication from India to sell to poor patients who couldn't afford the high cost of officially licensed drugs. The real-life businessman, who is believed to have saved more than 1,000 lives through his illicit sales, was briefly jailed but ultimately freed by a Chinese judge because of his altruism.

The story has been described as China's version of Dallas Buyers Club, the 2013 Matthew McConaughey film about a Texas man who sold unregulated AIDS drugs to help fellow HIV sufferers.

China's drug policy overhaul got a further boost on Monday, when the country's foreign ministry announced that it had reached a deal with India to reduce tariffs on the import of Indian medicines, especially cancer drugs. "We have decided to expand our imports as well as opening up," ministry spokeswoman Hua Chunying told the media at a briefing in Beijing. "There is a popular movie now in China called Dying to Survive. That movie is about zero tariffs imposition on anti-cancer medicines in China."

Local critics have hailed Dying to Survive as a creative breakthrough for the Chinese film industry because of both its fine craftsmanship and for the way it addresses an urgent national social problem — an approach often precluded by the country's notoriously strict censorship system. The coordinated timing of the film's release and the People's Daily report suggests that the authorities may have anticipated the film's popularity and decided to use the opportunity to institute reforms and generate some popular good will in the process.

China is the world’s second-largest pharmaceuticals market, trailing only the U.S. Drug sales in China totaled $123 billion last year, according to London-based L.E.K. Consulting. The country is also a key growth market for pharmaceutical companies that produce cancer drugs, with an average of 4.3 million new diagnoses each year.

The impact of China's price cuts will have major ramifications for both patients and drug producers. Medications already covered under China's state-backed insurance system will see their prices reduced by about 10 percent, while cancer drugs newly added to the state scheme could see their prices plummet by more than half, Zhao Heng of consultancy Latitude Health told the Financial Times Tuesday. 

Source: The Hollywood Reporter by Patrick Brzeski

$113m-budget Chinese fantasy film ‘Asura’ to hit mainland theaters

$
0
0

(Global Times) Boasting a 750 million yuan ($113.5 million) budget, Chinese fantasy production Asura will make its debut in the Chinese mainland on Friday, the film's producers announced on Monday.

The film is one of the most expensive mainland films in recent years.

The story follows the adventures of Ru Yi (Chinese actor Wu Lei), a young shepherd who one day learns he is the reincarnation of one of the heads of the three-headed king of the world known as Asura.

The Chinese studio worked closely with an A-class Hollywood production team that included costume designer Ngila Dickson, who worked on The Lord of the Rings trilogy, and Martin Mernandez, audio director for the Oscar-winning film The Revenant.

Aside from renowned Chinese actors such as Wu Lei, Tony Leung Ka-fai and Carina Lau, the ambitious Eastern epic also stars foreign performers such as Matthew Knowles and Bonetics, the 18-year-old body-twister from the 2015 season of Britain's Got Talent.

Many of the film's scenes were shot in the remote areas of Northwest China including the Ningxia Hui Autonomous Region and the Qinghai-Tibet Plateau.

Calling the film a "world-class visual feast," the film's producer Yang Zhenjian - also the producer of the popular Painted Skin franchise - said at the premiere ceremony that "Asura faced numerous technological challenges, such as portraying three heads on a single body."

Source: Global Times 

Zhao Lusi poses for photo shoot

$
0
0

Actress Zhao Lusi


Source: Xinhua

Street shots of Nana Ouyang

$
0
0

Actress Nana Ouyang


Source: Xinhua

Fashion icon Angelababy releases new photos

$
0
0

Actress Angelababy


Source: Xinhua

Second season of ‘The Rap of China’ returns to promote ‘positive’ rap music featuring ‘Chinese elements’

$
0
0

(Global Times) Earlier this year, Chinese Hip Hop music experienced an unexpected downturn after critics accused the genre of promoting misogyny and drug use. Now it looks like the genre might finally be making an official comeback as popular music competition show The Rap of China begins its second season on Chinese streaming giant iQiyi this weekend with a new focus on positivity.

Unlike earlier this year when rappers - even those who shot to fame overnight via the first season of the show last year - were kicked off and even edited out of some Chinese variety shows and their works were removed from music platforms, in May the producers of the show were busy promoting its rappers, holding auditions nationwide and even extending opportunities to rappers in North America, provided they could rap in Chinese.

"The new season of The Rap of China will be younger, more Chinese-style, more diverse, more positive and more trendy," concluded iQiyi CEO Gong Yu at the show's launch ceremony in Beijing on July 3.

While its English title remains unchanged, the second season of the iQiyi show is scheduled to debut on the streaming platform this Saturday under a new Chinese name: Zhongguo Xin Shuochang (lit. China New Rap), instead of the first season's Zhongguo You Xiha (lit. China Has Hip Hop).

But the new show's competition rules, stage setting as well as members of the judges panel, or "celebrity producers" as they are called on the show, remain nearly identical to the first season.

New direction

According to the show's producers, the name change was to emphasize the show's new direction instead of, as many netizens have speculated, an attempt to avoid censorship.

"We believe 'China Has Hip Hop' accomplished its historical task by introducing hip hop music to the Chinese public. 'China New Rap' is going to be a whole new show in which we will continue to explore what responsibilities rappers should shoulder after they make their public debut,"Rap of China producer Chen Wei told media during an interview.

Starting from the show's first round of auditions, the team this year focused more time and effort into examining candidates' history and "unhealthy habits," according to an article from Chinese music industry news site China Music Business - probably to prevent the entry of yet another PG One, the champion of the show's first season whose songs were removed from Chinese streaming platforms in January after netizens accused him of insulting women and promoting drug use with his hip hop song "Christmas Eve."

In May, the show released a 28-second promotional video that features Chinese singer/actor and returning first season judge Kris Wu stating that the show will "demonstrate positive energy and lofty emotions through rapping" - also one of the show's new slogans that have frequently appeared in advertising campaigns.

"We will also introduce a lot of Chinese elements in rap music, which will hopefully give audiences a fresh impression of our show,"Rap of China director Che Che said at the launch.

Market on the rise

Positive about the future of the Chinese hip hop music market, both Chen and Che mentioned that the market is returning to a more rational state after the huge explosion it experienced last year.

"Thanks to the first season of the show, many rap terms are no longer foreign concepts to many Chinese viewers, but the popularity that the show brought [to the genre] was somewhat overrated," Chen said.

"With the market becoming more and more rational, we as a public platform should convey a more responsible attitude via the show by portraying hip hop culture not as just the latest trendy thing, but also as a quality product that has positive values," the producer said.

To better convey this idea, the show will launch a series of new derivative products including a tie-in music festival.

Aside from making rap culture a business, Chen said they're also planning to promote the culture as a new lifestyle via The Rap of China.

"Young audiences will get a sense of a new lifestyle and attitude while watching the show. Most likely they will share and discuss this attitude with their peers; they might even go on to adopt this attitude or lifestyle if they feel that it makes them feel special and happy," Chen noted.

Che also recalled how young fans shouted out the names of the student rappers and celebrated their music during the show's auditions held at universities and colleges at home and abroad this year, saying that he was impressed by these college rappers' enormous popularity among their peers.

"I think that's because hip hop music really clicks with the aesthetic and values of young Chinese today," Che said.

"Honestly, I felt this was becoming a trend back in 2015 when I was directing Heroes of Remix [a 2016 Chinese electronic dance music show]," he noted.

Source: Global Times By Huang Tingting

Kevin Tsai, Dee Hsu’s new variety show fails to impress

$
0
0

(Toggle) Tears were shed when Taiwanese variety series Here Comes Kangxi, helmed by Kevin Tsai and Dee Hsu, ended its run after 12 years in 2015. Naturally, fans rejoiced when it was announced that the duo will be pairing up again to host a brand new variety series in China called Zhen Xiang Ba! Hua Hua Wan Wu.

The China-produced internet programme was revealed to have a production value of RMB 60 million (approximately S$12.2 million) and boasts a stellar lineup of special guests such as Lin Chi-ling, Lin Gengxin, Ouyang Nana, and Barbie Hsu and her husband Wang Xiaofei, to name a few.

However, the show failed to live up to its hype despite a strong debut of more than a million clicks for its first episode which featured Chinese comedienne Xie Na.

Chinese microblogging platform Weibo was rife with discussions about the talk show – and not in a good way, after its debut episode aired. Some netizens remarked that it was “awkward” to watch while some felt that Dee, a Taiwanese, was not suitable to host a programme in China owing to the differences in both countries’ cultures.

Another netizen felt that the additional special effects and gags were unnecessary frills with both Kevin and Dee at helm. “It’s like having an Alessandro Michele design and inviting dozens of celebs to walk the runway. It’s unnecessary and takes away the attention [from the hosts]. It’s a pity,” said netizen expressed.

Source: Toggle
Viewing all 18266 articles
Browse latest View live